Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
Limited information is currently available on LY01005, a putative extended release formulation of Goserelin (Aug 2018).
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|LY01005||LY-01005||Hormone - Anti-androgens 27||LY01005 is a extended release formulation of Goserelin, which is a synthetic analog of lutenizing hormone-releasing hormone (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT03450109||Phase I||LY01005 Goserelin||A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX) in Patients With Prostate Cancer||Completed|